TAMs facilitate ovarian cancer cell invasion through c-Jun and NF-κB signaling [34], whereas MDSCs inhibit T-cell activation and enhance cancer stem cell gene expression, sphere formation, and metastasis in ovarian cancer [35]. Here, NFKB1 is linked to ovarian carcinoma.